Literature DB >> 28087985

Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.

Gail A Cresci1,2,3,4, Bryan Glueck1, Megan R McMullen1, Wei Xin5, Daniella Allende6, Laura E Nagy1,7.   

Abstract

BACKGROUND AND AIM: Impaired gut-liver axis is a potential factor contributing to alcoholic liver disease. Ethanol depletes intestinal integrity and causes gut dysbiosis. Butyrate, a fermentation byproduct of gut microbiota, is altered negatively following chronic ethanol exposure. This study aimed to determine whether prophylactic tributyrin could protect the intestinal barrier and liver in mice during combined chronic-binge ethanol exposure.
METHODS: C57BL/6J mice exposed to 5% v/v ethanol-containing diet for 10 days received a single ethanol gavage (5 g/kg) 9 h before euthanasia. Control mice were isocalorically pair-fed maltose dextrin for ethanol. Diets were supplemented (5 mM) with tributyrin or glycerol. Intestine and liver disease activity was assessed histologically. Protein and mRNA expression of tight junction (TJ) proteins, toll-like receptors, and tumor necrosis factor-alpha were assessed. Caco-2 monolayers with or without ethanol exposure and/or sodium butyrate were used to test butyrate's direct effects on intestinal integrity.
RESULTS: Chronic-binge ethanol feeding impaired intestinal TJ protein co-localization staining; however, tributyrin co-treatment mitigated these effects. Ethanol depleted TJ and transepithelial electrical resistance in Caco-2 monolayers, but butyrate co-treatment reduced these effects. Hepatic toll-like receptor mRNA expression and tumor necrosis factor-alpha protein expression was induced by ethanol; however, the response was significantly dampened in mice co-treated with tributyrin. Tributyrin altered localization of both neutrophils and single hepatocyte death: Leukocytes and apoptotic hepatocytes localized predominantly around the portal tract in ethanol-only treated mice, whereas localization predominated around the central vein in ethanol-tributyrin mice.
CONCLUSIONS: Prophylactic tributyrin supplementation mitigated effects of combined chronic-binge ethanol exposure on disruption of intestinal TJ localization and intestinal permeability and liver injury.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  alcoholic liver disease; chronic-binge ethanol; gut permeability; tight junction proteins; tributyrin

Mesh:

Substances:

Year:  2017        PMID: 28087985      PMCID: PMC5511097          DOI: 10.1111/jgh.13731

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  56 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

2.  Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice.

Authors:  Megan R McMullen; Michele T Pritchard; Qifang Wang; Carrie A Millward; Colleen M Croniger; Laura E Nagy
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

3.  Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability.

Authors:  Takuya Suzuki; Shoko Yoshida; Hiroshi Hara
Journal:  Br J Nutr       Date:  2008-03-18       Impact factor: 3.718

4.  Histone Deacetylase Gene Expression Following Binge Alcohol Consumption in Rats and Humans.

Authors:  Jose Antonio López-Moreno; Miguel Marcos; Javier Calleja-Conde; Victor Echeverry-Alzate; Kora M Bühler; Pilar Costa-Alba; Edgar Bernardo; Francisco-Javier Laso; Fernando Rodríguez de Fonseca; Roser Nadal; Maria Paz Viveros; Rafael Maldonado; Elena Giné
Journal:  Alcohol Clin Exp Res       Date:  2015-09-13       Impact factor: 3.455

5.  Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.

Authors:  Ece Mutlu; Ali Keshavarzian; Phillip Engen; Christopher B Forsyth; Masoumeh Sikaroodi; Patrick Gillevet
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

6.  Chronic ethanol consumption alters mammalian gastrointestinal content metabolites.

Authors:  Guoxiang Xie; Wei Zhong; Xiaojiao Zheng; Qiong Li; Yunping Qiu; Houkai Li; Huiyuan Chen; Zhanxiang Zhou; Wei Jia
Journal:  J Proteome Res       Date:  2013-06-14       Impact factor: 4.466

7.  Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity.

Authors:  Sophie Leclercq; Sébastien Matamoros; Patrice D Cani; Audrey M Neyrinck; François Jamar; Peter Stärkel; Karen Windey; Valentina Tremaroli; Fredrik Bäckhed; Kristin Verbeke; Philippe de Timary; Nathalie M Delzenne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

8.  Volatile fatty acids in human peripheral and portal blood: quantitative determination vacuum distillation and gas chromatography.

Authors:  J Dankert; J B Zijlstra; B G Wolthers
Journal:  Clin Chim Acta       Date:  1981-03-05       Impact factor: 3.786

9.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

10.  Repair of damaged intestinal mucosa in a mouse model of sepsis.

Authors:  Rui-Ming Chang; Li-Qiang Wen; Jian-Xing Chang; Yu-Ru Fu; Zhi-Peng Jiang; Shuang Chen
Journal:  World J Emerg Med       Date:  2013
View more
  46 in total

Review 1.  Inflammatory pathways in alcoholic steatohepatitis.

Authors:  Bin Gao; Maleeha F Ahmad; Laura E Nagy; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 2.  Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease.

Authors:  Eric K Kwong; Puneet Puri
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

3.  The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice.

Authors:  Carlos Sanz-Garcia; Kyle L Poulsen; Damien Bellos; Han Wang; Megan R McMullen; Xiaoxia Li; Saurabh Chattopadhyay; Ganes Sen; Laura E Nagy
Journal:  J Hepatol       Date:  2019-01-31       Impact factor: 25.083

4.  Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs.

Authors:  Zdenek Dvorak; Max Klapholz; Thomas P Burris; Benjamin P Willing; Antimo Gioiello; Roberto Pellicciari; Francesco Galli; John March; Stephen J O'Keefe; R Balfour Sartor; Chang H Kim; Maayan Levy; Sridhar Mani
Journal:  Mol Pharmacol       Date:  2020-08-06       Impact factor: 4.436

5.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

6.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

7.  Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: Role of gut-liver-adipose tissue axis.

Authors:  Youngshim Choi; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  J Nutr Biochem       Date:  2017-12-10       Impact factor: 6.048

8.  Disrupted diurnal oscillation of gut-derived Short chain fatty acids in shift workers drinking alcohol: Possible mechanism for loss of resiliency of intestinal barrier in disrupted circadian host.

Authors:  Garth R Swanson; Joel Siskin; Annika Gorenz; Maliha Shaikh; Shohreh Raeisi; Louis Fogg; Christopher Forsyth; Ali Keshavarzian
Journal:  Transl Res       Date:  2020-05-05       Impact factor: 7.012

Review 9.  The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-07       Impact factor: 46.802

Review 10.  Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting.

Authors:  Matias A Avila; Jean-François Dufour; Alexander L Gerbes; Fabien Zoulim; Ramon Bataller; Patrizia Burra; Helena Cortez-Pinto; Bin Gao; Ian Gilmore; Philippe Mathurin; Christophe Moreno; Vladimir Poznyak; Bernd Schnabl; Gyongyi Szabo; Maja Thiele; Mark R Thursz
Journal:  Gut       Date:  2019-12-26       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.